Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Daniel B. Roquini"'
Autor:
Daniel B. Roquini, Bruna L. Lemes, Amanda L. B. Kreutz, Sophia C. Spoladore, Monique C. Amaro, Flavia B. Lopes, João Paulo S. Fernandes, Josué de Moraes
Publikováno v:
ACS Omega, Vol 9, Iss 28, Pp 31159-31165 (2024)
Externí odkaz:
https://doaj.org/article/4f9085578d2949c48e07cce2889977dd
Autor:
Juliana R. Brito, Polrat Wilairatana, Daniel B. Roquini, Beatriz C. Parra, Marina M. Gonçalves, Dalete Christine S. Souza, Edgard A. Ferreira, Maria C. Salvadori, Fernanda S. Teixeira, João Henrique G. Lago, Josué de Moraes
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Schistosomiasis, a parasitic disease caused by the blood fluke of the genus Schistosoma, affects over 230 million people, especially in developing countries. Despite the significant economic and public health consequences, only one drug is c
Externí odkaz:
https://doaj.org/article/a9e7ccfca4364be6b77b4694ae667ba4
Autor:
Daniel B. Roquini, Gabriel L. Silva, Leonardo L. G. Ferreira, Adriano D. Andricopulo, Polrat Wilairatana, Josué De Moraes
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Human helminthiasis affects approximately one in five people in the world and disproportionally affects the poorest and most deprived communities. Human angiostrongyliasis, caused by nematode Angiostrongylus cantonensis, is a neglected emerging disea
Externí odkaz:
https://doaj.org/article/f8c8d9431cbe416babb044230574c041
Autor:
Edilaine S. Xavier, Rafael L. de Souza, Vinícius C. Rodrigues, Camila O. Melo, Daniel B. Roquini, Bruna L. Lemes, Polrat Wilairatana, Elquio E. Oliveira, Josué de Moraes
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Since praziquantel is the only drug available to treat schistosomiasis, a neglected parasitic disease that affects more than 240 million people worldwide, there is an urgent demand for new antischistosomal agents. Natural compound-loaded nanoparticle
Externí odkaz:
https://doaj.org/article/ac1a612d024b4edb84ebc8639083a5fd
Autor:
Rogério P. Xavier, Ana C. Mengarda, Marcos P. Silva, Daniel B. Roquini, Maria C. Salvadori, Fernanda S. Teixeira, Pedro L. Pinto, Thiago R. Morais, Leonardo L. G. Ferreira, Adriano D. Andricopulo, Josué de Moraes
Publikováno v:
Parasites & Vectors, Vol 13, Iss 1, Pp 1-12 (2020)
Abstract Background Schistosomiasis is a socioeconomically devastating parasitic infection afflicting hundreds of millions of people and animals worldwide. It is the most important helminth infection, and its treatment relies solely on the drug prazi
Externí odkaz:
https://doaj.org/article/2eb280a93e1a48be8e0834eceb1b9ebb
Autor:
Rafael L de Souza, Ana C Mengarda, Daniel B Roquini, Camila O Melo, Mayara C de Morais, Maria Cristina C Espírito-Santo, Damião P de Sousa, Josué de Moraes, Elquio E Oliveira
Publikováno v:
Nanomedicine. 18:331-342
Aim: To formulate a carvacryl acetate nanoemulsion (CANE) and test its antischistosomal activity. Materials & methods: CANE was prepared and tested in vitro on Schistosoma mansoni adult worms and both human and animal cell lines. Next, CANE was admin
Autor:
Ana C. Mengarda, Tais C. Silva, Aline S. Silva, Daniel B. Roquini, João Paulo S. Fernandes, Josué de Moraes
Publikováno v:
European Journal of Medicinal Chemistry. 251:115268
Autor:
Daniel B, Roquini, Gabriel L, Silva, Leonardo L G, Ferreira, Adriano D, Andricopulo, Polrat, Wilairatana, Josué, De Moraes
Publikováno v:
Frontiers in pharmacology. 13
Human helminthiasis affects approximately one in five people in the world and disproportionally affects the poorest and most deprived communities. Human angiostrongyliasis, caused by nematode
Autor:
Daniel B. Roquini, Josué de Moraes
Publikováno v:
International Journal of Medical Parasitology and Epidemiology Sciences. 3:1-2
Autor:
Ademar A. da Silva Filho, Marcos P. Silva, Fernanda de Sá Teixeira, Josué de Moraes, Daniel B. Roquini, Maria Cecília Barbosa da Silveira Salvadori, Damião Pergentino de Sousa, Rosimeire Nunes de Oliveira, Pedro Luiz Silva Pinto, Ana C. Mengarda, Silmara Marques Allegretti
Publikováno v:
International Journal of Antimicrobial Agents. 50:467-472
Schistosomiasis is a major public health problem worldwide, especially in poor communities. Since praziquantel is currently the only drug available to treat schistosomiasis, there is an urgent need to identify new antischistosomal drugs. Nerolidol is